Filing Flows › Bio-Techne (TECH) › Q1 FY27 › vs Q1 FY26
Bio-Techne (TECH) Q1 FY27 vs Q1 FY26 (year over year)
Bio-Techne's revenue rose $13.2M (+5%) from $287M in Q1 FY26 to $300M in Q1 FY27. The biggest changes: Royalty +$8.8M (+157%); Product and Services +$4.3M (+2%). Gross margin 65.6% against 65.6% (-0.0 pts).
Bio-Techne, Q1 FY27: revenue $300M (+5% year over year), operating margin 12.2%, net earnings $28.3M, operating cash flow $73.1M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Gross margin | 65.6% | 65.6% | -0.0 pts |
| Operating margin | 12.2% | 16.6% | -4.4 pts |
| Net margin | 9.4% | 13.3% | -3.9 pts |
| Free cash flow margin | 22.4% | 7.8% | +14.7 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Consumables | $237M | $232M | $5.7M | +2% |
| Instruments | $25.5M | $21.8M | $3.7M | +17% |
| Services | $22.5M | $27.5M | −$5.0M | -18% |
| Product and Services | $285M | $281M | $4.3M | +2% |
| Royalty | $14.5M | $5.6M | $8.8M | +157% |
| Revenue | $300M | $287M | $13.2M | +5% |
| Gross profit | $197M | $188M | $8.5M | +5% |
| Cost of revenue | $103M | $98.4M | $4.6M | +5% |
| Operating profit | $36.6M | $47.7M | −$11.1M | -23% |
| Operating expenses | $160M | $140M | $19.6M | +14% |
| Pre-tax earnings | $34.7M | $48.0M | −$13.3M | -28% |
| Other expense, net | $1.9M | −$333K | $2.2M | — |
| Research & development | $26.3M | $24.2M | $2.1M | +9% |
| SG&A | $134M | $116M | $17.5M | +15% |
| Net earnings | $28.3M | $38.2M | −$9.9M | -26% |
| Income tax | $6.4M | $9.8M | −$3.4M | -35% |
| Depreciation & amortization | $23.7M | $24.3M | −$614K | -3% |
| Share-based compensation | $13.4M | $11.7M | $1.7M | +15% |
| Working capital & other | $7.7M | −$46.6M | $54.3M | — |
| Operating cash flow | $73.1M | $27.6M | $45.5M | +165% |
| Free cash flow (OCF − capex) | $67.2M | $22.2M | $45.0M | +202% |
| Capital expenditures | $5.9M | $5.4M | $554K | +10% |
Questions
How much did Bio-Techne's revenue grow year over year in Q1 FY27?
Bio-Techne's revenue rose $13.2M (+5%) from $287M in Q1 FY26 to $300M in Q1 FY27.
What drove Bio-Techne's revenue change in Q1 FY27?
Royalty +$8.8M (+157%); Product and Services +$4.3M (+2%).